Home › NDC Lookup › RxCUI directory › RxCUI 1373137

Lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Topical Gel — RxCUI 1373137

RxNorm drug concept · Semantic clinical drug
RxCUI 1373137 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1373137
Official nameLidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslidocaine hydrochloride 4 % / menthol 1 % Topical Gel; lidocaine HCl 4 % / menthol 1 % Topical Gel
FDA products mapped11
Package NDCs mapped11
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
  • What is this patch actually for — why did my doctor prescribe it?
  • You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
  • How long do I wear the patch, and can I wear more than one?
📖 Read our full Lidocaine Transdermal Patch guide →

🕸️ Concept Web — How Lidocaine hydrochloride 0.04 MG/MG / menthol 0.0... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Topical Gel RxCUI 1373137

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Lidocaine 6387
    • Menthol 6750
    • Lidocaine / menthol 1008818
    • Lidocaine hydrochloride 142440
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lenzagel 1373138
    • Lidozen 1939336
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lidocaine / menthol Topical Gel 377985
    • Lidocaine hydrochloride / menthol Topical Gel 2649126
    • Lidocaine / menthol Topical Product 1164045
    • Lidocaine hydrochloride / menthol Topical Product 2661545
    • Lidocaine / menthol Topical Gel [Lenzagel] 1373140
    • Lidocaine / menthol Topical Gel [Lidozen] 1939338
    • Lidocaine hydrochloride / menthol Topical Gel [Lenzagel] 2657184
    • Lidocaine hydrochloride / menthol Topical Gel [Lidozen] 2657563
    • +4 more in this family
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Lidocaine hydrochloride 0.04 MG/MG 1010076
    • Menthol 0.01 MG/MG 331833
    • Lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Topical Gel [Lenzagel] 1373142
    • Lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Topical Gel [Lidozen] 1939340
    • Lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG [Lenzagel] 1373139
    • Lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG [Lidozen] 2592640

Showing up to 8 concepts per family — 20 of 24 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lidocaine hydrochloride 0.04 MG/MG SCDC · 1010076
  • Menthol 0.01 MG/MG SCDC · 331833
  • Lidocaine / menthol Topical Gel SCDF · 377985
  • Lidocaine hydrochloride / menthol Topical Gel SCDFP · 2649126
  • Lidocaine / menthol Topical Product SCDG · 1164045
  • Lidocaine hydrochloride / menthol Topical Product SCDGP · 2661545

Brand-Name Concepts

  • Lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Topical Gel [Lidozen] SBD · 1939340
  • Lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG Topical Gel [Lenzagel] SBD · 1373142
  • Lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG [Lenzagel] SBDC · 1373139
  • Lidocaine hydrochloride 0.04 MG/MG / menthol 0.01 MG/MG [Lidozen] SBDC · 2592640
  • Lidocaine / menthol Topical Gel [Lenzagel] SBDF · 1373140
  • Lidocaine / menthol Topical Gel [Lidozen] SBDF · 1939338
  • Lidocaine hydrochloride / menthol Topical Gel [Lenzagel] SBDFP · 2657184
  • Lidocaine hydrochloride / menthol Topical Gel [Lidozen] SBDFP · 2657563
  • Lenzagel Topical Product SBDG · 1373141
  • Lidozen Topical Product SBDG · 1939339

📦 FDA Products & Package NDCs

11 products · 11 package NDCs
11 package NDCs map to RxCUI 1373137 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10742-1389-01 1 BOTTLE in 1 CARTON (10742-1389-1) / 80 mL in 1 BOTTLE Mentholatum Lidocaine Ice The Mentholatum Company 2018-08-01
29784-0410-02 1 BOTTLE in 1 CARTON (29784-410-02) / 70.9 g in 1 BOTTLE Heal and Rescue Bunion Pain Relief Rooftop Consumer Health, Inc 2026-03-02
59088-0240-16 237 mL in 1 BOTTLE, PUMP (59088-240-16) Lidochill(TM) Gel PureTek Corporation 2025-09-08
63187-0892-72 1 BOTTLE in 1 BOX (63187-892-72) / 120 mL in 1 BOTTLE Lidozen Proficient Rx LP 2017-08-01
71205-0715-72 120 mL in 1 BOTTLE (71205-715-72) Lidozen Gel Proficient Rx LP 2022-11-11
71574-0300-72 1 BOTTLE in 1 BOX (71574-300-72) / 120 mL in 1 BOTTLE Lidozen Village Pharma, LLC 2017-07-22
71574-0305-72 120 mL in 1 BOTTLE (71574-305-72) Lidozen Gel Village Pharma LLC 2022-09-01
72839-0014-03 85 g in 1 BOTTLE (72839-014-03) DCH Nerve Pain Relief Roll-On Derma Care Research Labs, LLC 2023-05-30
76420-0145-04 1 TUBE in 1 BOX (76420-145-04) / 118.3 g in 1 TUBE Zylotrol Asclemed USA, Inc. 2022-06-12
81902-0201-04 1 TUBE in 1 BOX (81902-201-04) / 118.3 g in 1 TUBE Zylotrol Whitestone Products LLC 2022-01-04
82714-0001-01 1 APPLICATOR in 1 CARTON (82714-001-01) / 85 g in 1 APPLICA... BlueStop Max Clavel Corporation 2023-01-10
Observed labelers: Proficient Rx LP (2) · Asclemed USA, Inc. (1) · Clavel Corporation (1) · Derma Care Research Labs, LLC (1) · PureTek Corporation (1) · Rooftop Consumer Health, Inc (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.